Published in Pharmacol Rev on June 25, 2008
ELITE: Early Versus Late Intervention Trial With Estradiol | NCT00114517
Kronos Early Estrogen Prevention Study (KEEPS) | NCT00154180
Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain (2009) 5.62
From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev (2010) 3.11
Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res (2009) 2.16
Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev (2010) 2.13
Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology (2009) 2.10
Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol (2009) 2.01
Sex and ageing differences in resting arterial pressure regulation: the role of the β-adrenergic receptors. J Physiol (2011) 2.00
Premature menopause or early menopause and risk of ischemic stroke. Menopause (2012) 1.84
Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction. Plast Reconstr Surg (2012) 1.54
Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain (2012) 1.40
Cellular signaling and NO production. Pflugers Arch (2010) 1.38
Sex, ageing and resting blood pressure: gaining insights from the integrated balance of neural and haemodynamic factors. J Physiol (2012) 1.38
Neuroprotective effects of estrogens following ischemic stroke. Front Neuroendocrinol (2009) 1.28
Hormonal modulation of endothelial NO production. Pflugers Arch (2010) 1.26
Estradiol-17beta and its cytochrome P450- and catechol-O-methyltransferase-derived metabolites stimulate proliferation in uterine artery endothelial cells: role of estrogen receptor-alpha versus estrogen receptor-beta. Hypertension (2010) 1.24
Non-genomic regulation of vascular cell function and growth by estrogen. Mol Cell Endocrinol (2009) 1.21
Epigenetics in atherosclerosis and inflammation. J Cell Mol Med (2010) 1.21
The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascul Pharmacol (2011) 1.18
Social stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptation. Am J Primatol (2009) 1.16
Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia. J Cereb Blood Flow Metab (2009) 1.12
Rapid effects of estrogen on intracellular Ca2+ regulation in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2010) 1.08
Vascular endothelial estrogen receptor alpha is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women. J Clin Endocrinol Metab (2009) 1.07
Sex differences and sex steroids in lung health and disease. Endocr Rev (2012) 1.07
The role of redox signaling in epigenetics and cardiovascular disease. Antioxid Redox Signal (2013) 1.03
Relationship between muscle sympathetic nerve activity and aortic wave reflection characteristics in young men and women. Hypertension (2011) 1.03
Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke. J Pharmacol Exp Ther (2009) 1.02
Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels. Curr Med Chem (2009) 1.01
Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender. Lipids Health Dis (2010) 1.01
Estrogen-receptor-mediated protection of cerebral endothelial cell viability and mitochondrial function after ischemic insult in vitro. J Cereb Blood Flow Metab (2009) 1.01
Sex/gender medicine. The biological basis for personalized care in cardiovascular medicine. Circ J (2009) 1.01
Fructose and uric acid: is there a role in endothelial function? Curr Hypertens Rep (2014) 1.01
Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease. Mini Rev Med Chem (2012) 0.99
Circulating microparticles and endogenous estrogen in newly menopausal women. Climacteric (2009) 0.98
Neuroprotective efficacy of estrogen in experimental spinal cord injury in rats. Ann N Y Acad Sci (2010) 0.97
Role of endothelial soluble epoxide hydrolase in cerebrovascular function and ischemic injury. PLoS One (2013) 0.97
Arterial Stiffness: A Nexus between Cardiac and Renal Disease. Cardiorenal Med (2014) 0.97
A novel role for an endothelial adrenergic receptor system in mediating catecholestradiol-induced proliferation of uterine artery endothelial cells. Hypertension (2011) 0.94
Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics (2012) 0.93
Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease. Curr Drug Metab (2010) 0.92
MnSOD protects against COX1-mediated endothelial dysfunction in chronic heart failure. Am J Physiol Heart Circ Physiol (2010) 0.90
Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease. Biochem Pharmacol (2013) 0.90
Unraveling the mechanisms underlying the rapid vascular effects of steroids: sorting out the receptors and the pathways. Br J Pharmacol (2011) 0.89
Estrogen effects on human airway smooth muscle involve cAMP and protein kinase A. Am J Physiol Lung Cell Mol Physiol (2012) 0.88
Should there be sex-specific criteria for the diagnosis and treatment of heart failure? J Cardiovasc Transl Res (2013) 0.87
17β-Estradiol prevents cell death and mitochondrial dysfunction by an estrogen receptor-dependent mechanism in astrocytes after oxygen-glucose deprivation/reperfusion. Free Radic Biol Med (2012) 0.87
Increased estrogen receptor alpha in experimental aortic aneurysms in females compared with males. J Surg Res (2013) 0.87
PPARγ activation rescues mitochondrial function from inhibition of complex I and loss of PINK1. Exp Neurol (2013) 0.87
Sex steroid signaling: implications for lung diseases. Pharmacol Ther (2015) 0.86
Vascular disease in diabetic women: Why do they miss the female protection? Exp Diabetes Res (2012) 0.86
Molecular regulation of human placental growth factor (PlGF) gene expression in placental villi and trophoblast cells is mediated via the protein kinase a pathway. Reprod Sci (2010) 0.85
Estrogen promotes Leydig cell engulfment by macrophages in male infertility. J Clin Invest (2014) 0.85
Vascular Aging in Women: is Estrogen the Fountain of Youth? Front Physiol (2012) 0.85
17beta-estradiol attenuates vascular contraction through inhibition of RhoA/Rho kinase pathway. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.85
Estradiol stimulates capillary formation by human endothelial progenitor cells: role of estrogen receptor-{alpha}/{beta}, heme oxygenase 1, and tyrosine kinase. Hypertension (2010) 0.84
Human uterine and placental arteries exhibit tissue-specific acute responses to 17β-estradiol and estrogen-receptor-specific agonists. Mol Hum Reprod (2013) 0.84
Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists. Biol Sex Differ (2011) 0.84
Sex, hormones and neuroeffector mechanisms. Acta Physiol (Oxf) (2010) 0.83
Aging negatively affects estrogens-mediated effects on nitric oxide bioavailability by shifting ERα/ERβ balance in female mice. PLoS One (2011) 0.83
Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause. Biol Sex Differ (2013) 0.83
Is tamoxifen associated with an increased risk for thromboembolic complications in patients undergoing microvascular breast reconstruction? Ger Med Sci (2013) 0.83
Mechanisms of cerebrovascular protection: oestrogen, inflammation and mitochondria. Acta Physiol (Oxf) (2010) 0.82
Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease. Womens Health (Lond Engl) (2015) 0.82
Local oestrogenic/androgenic balance in the cerebral vasculature. Acta Physiol (Oxf) (2011) 0.82
Notable epigenetic role of hyperhomocysteinemia in atherogenesis. Lipids Health Dis (2014) 0.82
Diesel exhaust particulate extracts inhibit transcription of nuclear respiratory factor-1 and cell viability in human umbilical vein endothelial cells. Arch Toxicol (2011) 0.81
Comorbid health conditions in women with syncope. Clin Auton Res (2010) 0.81
Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease. Cardiovasc Hematol Agents Med Chem (2010) 0.80
Role of lipoxygenase metabolites of arachidonic acid in enhanced pulmonary artery contractions of female rabbits. Hypertension (2011) 0.80
Mechanism of the sex difference in endothelial dysfunction after stroke. Transl Stroke Res (2013) 0.80
Myocardial contractility is preserved early but reduced late after ovariectomy in young female rats. Reprod Biol Endocrinol (2011) 0.80
Relationship between Postmenopausal Estrogen Deficiency and Aneurysmal Subarachnoid Hemorrhage. Behav Neurol (2015) 0.79
17β-Estradiol induces vasorelaxation in a G-protein-coupled receptor 30-independent manner. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.79
Estrogen and mitochondria function in cardiorenal metabolic syndrome. Prog Mol Biol Transl Sci (2014) 0.79
Autonomic Cardiovascular Damage during Post-menopause: the Role of Physical Training. Aging Dis (2013) 0.79
Androgens and the cerebrovasculature: modulation of vascular function during normal and pathophysiological conditions. Pflugers Arch (2013) 0.78
Estrogens and selective estrogen receptor modulators regulate gene and protein expression in the mesenteric arteries. Vascul Pharmacol (2011) 0.78
The molecular actions of oestrogen in the regulation of vascular health. Exp Physiol (2016) 0.78
Cardiomyocyte-specific Estrogen Receptor Alpha Increases Angiogenesis, Lymphangiogenesis and Reduces Fibrosis in the Female Mouse Heart Post-Myocardial Infarction. J Cell Sci Ther (2014) 0.78
Implications for reproductive medicine: Sex differences in cardiovascular disease. Sex Reprod Menopause (2011) 0.78
Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female mice. Am J Physiol Heart Circ Physiol (2011) 0.78
Endothelial biology in the post-menopausal obese woman. Maturitas (2011) 0.78
Sympathetic restraint of muscle blood flow during hypoxic exercise. Am J Physiol Regul Integr Comp Physiol (2009) 0.77
Effects of estradiol on transcriptional profiles in atherosclerotic iliac arteries in ovariectomized cynomolgus macaques. Menopause (2014) 0.77
Congress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular disease. J Womens Health (Larchmt) (2014) 0.77
Dynamics of enhanced mitochondrial respiration in female compared with male rat cerebral arteries. Am J Physiol Heart Circ Physiol (2015) 0.77
Therapeutic Efficacy of an ω-3-Fatty Acid-Containing 17-β Estradiol Nano-Delivery System against Experimental Atherosclerosis. PLoS One (2016) 0.77
Endogenous female sex hormones delay the development of renal dysfunction in apolipoprotein E-deficient mice. Lipids Health Dis (2014) 0.76
Effects of equol on gene expression in female cynomolgus monkey iliac arteries. Nutr Metab Cardiovasc Dis (2013) 0.76
Use of 3D pseudo-continuous arterial spin labeling to characterize sex and age differences in cerebral blood flow. Neuroradiology (2016) 0.76
Alike but not the same: anatomic heterogeneity of estrogen receptor-mediated vasodilation. J Cardiovasc Pharmacol (2013) 0.76
Influence of estradiol supplementation on neuropeptide Y neurotransmission in skeletal muscle arterioles of F344 rats. Am J Physiol Regul Integr Comp Physiol (2012) 0.76
Polymorphisms in the LPL and CETP Genes and Haplotype in the ESR1 Gene Are Associated with Metabolic Syndrome in Women from Southwestern Mexico. Int J Mol Sci (2015) 0.76
Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia. Curr Hypertens Rep (2017) 0.75
Heart Disease in Women: Unappreciated Challenges, GPER as a New Target. Int J Mol Sci (2016) 0.75
Sex hormone therapy and progression of cardiovascular disease in menopausal women. Clin Sci (Lond) (2016) 0.75
Vasorelaxation Effect of Estrone Derivate EA204 in Rabbit Aorta. Scientifica (Cairo) (2016) 0.75
Imaging of estrogen receptor-α in rat pial arterioles using a digital immunofluorescent microscope. J Vis Exp (2011) 0.75
Differential effects of hormone therapy on serotonin, vascular function and mood in the KEEPS. Climacteric (2015) 0.75
17β-estradiol ameliorates oxygen-induced retinopathy in the early hyperoxic phase. Biochem Biophys Res Commun (2015) 0.75
Reproductive senescence blunts response of estrogen receptor-α expression to estrogen treatment in rat post-ischemic cerebral microvessels. PLoS One (2014) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Inflammation in atherosclerosis. Nature (2002) 28.92
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet (2005) 16.79
Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 14.72
Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A (1996) 10.94
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell (2006) 10.18
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med (1999) 10.16
A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science (2005) 9.80
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet (2000) 8.79
Estrogen therapy and coronary-artery calcification. N Engl J Med (2007) 8.70
Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci (2003) 8.23
Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A (1993) 7.13
Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev (1999) 7.06
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation (2003) 6.99
Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A (1994) 6.96
Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol (2005) 6.90
Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med (1994) 6.59
The protective effects of estrogen on the cardiovascular system. N Engl J Med (1999) 6.25
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med (2006) 6.14
Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med (2002) 6.00
Mechanisms of estrogen action. Physiol Rev (2001) 5.97
Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration? Thromb Haemost (2007) 5.91
Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A (1998) 5.86
Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol (2004) 5.34
Estrogen receptors: how do they signal and what are their targets. Physiol Rev (2007) 5.27
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature (1998) 5.21
Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology (2004) 5.20
Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med (2006) 5.10
Integrins regulate Rac targeting by internalization of membrane domains. Science (2004) 5.07
Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development (2000) 5.03
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 4.91
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. Clin Pharmacol Ther (2006) 4.81
Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation (2005) 4.49
The complex role of estrogens in inflammation. Endocr Rev (2007) 4.07
Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol (2004) 4.02
Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med (2006) 3.91
Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol (2006) 3.81
Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med (2002) 3.68
The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology (1999) 3.67
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med (1992) 3.54
Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci U S A (1997) 3.53
Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol (1985) (2006) 3.42
The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol (2007) 3.39
Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem (2000) 3.34
Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem (2001) 3.24
Estrogen and coronary heart disease in women. JAMA (1991) 3.17
Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med (2004) 3.12
Mitochondrial dysfunction in atherosclerosis. Circ Res (2007) 3.09
Cardiovascular health and disease in women. N Engl J Med (1993) 3.08
Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2001) 3.03
Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation (2005) 3.01
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol (2006) 2.97
Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology (1997) 2.94
Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation (2006) 2.93
Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. JAMA (2004) 2.93
Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol (2006) 2.90
Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv (2003) 2.88
Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) (2006) 2.77
Extranuclear steroid receptors: nature and actions. Endocr Rev (2007) 2.72
Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest (1999) 2.71
Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). Arch Intern Med (2007) 2.62
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol (2006) 2.57
Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med (1997) 2.52
Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling. Science (2003) 2.49
Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science (2002) 2.45
Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol (2004) 2.42
Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation (2006) 2.40
High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med (2000) 2.39
Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol (1985) (2001) 2.33
Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci (2005) 2.32
KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric (2005) 2.32
Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology (2005) 2.31
Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) (2006) 2.24
Postmenopausal hormone therapy in clinical perspective. Menopause (2007) 2.23
Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab (2002) 2.22
27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med (2007) 2.18
Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol (2003) 2.17
Regulation of signal transduction pathways by estrogen and progesterone. Annu Rev Physiol (2005) 2.17
Sex difference in resting pituitary-adrenal function in the rat. Am J Physiol (1963) 2.17
Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke (2006) 2.17
Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism. J Thromb Haemost (2006) 2.17
International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev (2006) 2.15
Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A (2004) 2.15
Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ Res (2006) 2.14
Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA (2003) 2.10
Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. Arterioscler Thromb Vasc Biol (2007) 2.08
Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol Biol Cell (2004) 2.07
HRT and the young at heart. N Engl J Med (2007) 2.07
Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine (2002) 2.06
Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res (2002) 2.05
High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women. J Vasc Surg (2000) 2.03
Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation (2006) 2.02
Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol (2004) 2.00
Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension (2006) 1.99
Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol (1985) (2006) 1.88
Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol (2005) 1.75
Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects. Mol Pharmacol (2004) 1.31
17beta-estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase. Stroke (2002) 1.26
Estrogen suppresses brain mitochondrial oxidative stress in female and male rats. Brain Res (2007) 1.25
Multiple forms of estrogen receptor-alpha in cerebral blood vessels: regulation by estrogen. Am J Physiol Endocrinol Metab (2002) 1.24
Mitochondrial effects of estrogen are mediated by estrogen receptor alpha in brain endothelial cells. J Pharmacol Exp Ther (2008) 1.24
17beta-estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation. Am J Physiol Heart Circ Physiol (2003) 1.17
Testosterone treatment increases thromboxane function in rat cerebral arteries. Am J Physiol Heart Circ Physiol (2005) 1.07
Estrogen-receptor-mediated protection of cerebral endothelial cell viability and mitochondrial function after ischemic insult in vitro. J Cereb Blood Flow Metab (2009) 1.01
Testosterone suppresses endothelium-dependent dilation of rat middle cerebral arteries. Am J Physiol Heart Circ Physiol (2003) 1.01
Testosterone augments endotoxin-mediated cerebrovascular inflammation in male rats. Am J Physiol Heart Circ Physiol (2005) 1.00
Estrogen suppresses IL-1beta-mediated induction of COX-2 pathway in rat cerebral blood vessels. Am J Physiol Heart Circ Physiol (2003) 1.00
Estrogen and progestagens differentially modulate vascular proinflammatory factors. Am J Physiol Endocrinol Metab (2006) 0.97
Age alters cerebrovascular inflammation and effects of estrogen. Am J Physiol Heart Circ Physiol (2007) 0.95
17 Beta-estradiol increases endothelial nitric oxide synthase mRNA copy number in cerebral blood vessels: quantification by real-time polymerase chain reaction. Eur J Pharmacol (2003) 0.94
Androgenic/estrogenic balance in the male rat cerebral circulation: metabolic enzymes and sex steroid receptors. J Cereb Blood Flow Metab (2007) 0.93
Dihydrotestosterone stimulates cerebrovascular inflammation through NFkappaB, modulating contractile function. J Cereb Blood Flow Metab (2008) 0.92
Effect of estrogen on cerebrovascular prostaglandins is amplified in mice with dysfunctional NOS. Am J Physiol Heart Circ Physiol (2004) 0.90
Chronic hypoxia alters the function of NOS nerves in cerebral arteries of near-term fetal and adult sheep. J Appl Physiol (1985) (2002) 0.87
17β-Estradiol prevents cell death and mitochondrial dysfunction by an estrogen receptor-dependent mechanism in astrocytes after oxygen-glucose deprivation/reperfusion. Free Radic Biol Med (2012) 0.87
Male-female differences in the relative contribution of endothelial vasodilators released by rat tail artery. Life Sci (2002) 0.85
Endogenous ovarian hormones affect mitochondrial efficiency in cerebral endothelium via distinct regulation of PGC-1 isoforms. J Cereb Blood Flow Metab (2012) 0.82
Regional differences in the effect of oestrogen on vascular tone in isolated rabbit arteries. Pharmacol Toxicol (2002) 0.77
Aging and calcium buffering in adrenergic neurons. Auton Neurosci (2002) 0.76
Vascular neuroeffector mechanisms: the next 30 years. Trends Pharmacol Sci (2002) 0.75
[Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial function]. Sheng Li Ke Xue Jin Zhan (2010) 0.75